Pharmaceutical Company Yarora Lifesciences LLP was incepted in 2017 with the singular objective of  establishing a strong presence in the global healthcare market. Operating from Mumbai as our headquarters, we have developed a robust international footprint spanning Asia, Africa, CIS, Europe and Latin America.

Within a short period, Yarora has achieved a notable position in the pharmaceutical sector, with focused expertise in biosimilars, orphan drugs, ophthalmic preparations, and injectable formulations. Our portfolio includes over 200 pharmaceutical formulations across various dosage forms, marketed successfully across the multiple international territories.

Our Approach

At Yarora, we consistently monitor market dynamics, healthcare trends, and regulatory evolutions guided by global healthcare frameworks and recommendations from organizations such as the World Health Organization (WHO) and other international regulatory authorities. This enables us to strategically realign our product mix, distribution channels, and operational resources to capture emerging opportunities while ensuring sustainable growth.

Quality Commitment

Quality is deeply embedded in our organizational culture. We adhere to stringent internal quality standards supported by experienced professionals who uphold our guiding principle of “Customer First.” Our teams continuously work to ensure that every product meets the highest global pharmaceutical standards while supporting our broader pharmaceutical product portfolio and long-term healthcare partnerships.

Our manufacturing facilities operate in compliance with globally recognized regulatory standards, including EU-GMP and WHO-GMP, ensuring consistent product quality, safety, and regulatory acceptance worldwide. Through our commitment to quality and regulatory excellence, we are able to deliver reliable medicines across global markets. To learn more about our offerings and capabilities, explore our Products portfolio or reach out through our Contact Us page for further information.